Reversal effect of Tween-20 on multidrug resistance in tumor cells in vitro

作者: Shouhui Yang , JinJuan Liu , Yongqiang Chen , Jihong Jiang

DOI: 10.1016/J.BIOPHA.2011.10.007

关键词:

摘要: Multidrug resistance (MDR) is a major barrier for chemotherapy of many cancers. Non-ionic surfactants have great potential to reverse the MDR by preventing onset or delay progression carcinogenic process. However, role Tween-20 in development remains unknown. The aim this study was explore reversal effect and mechanism on tumor cells vitro. Alamar Blue assay used examine index vincristine (VCR), doxorubicin (DOX) 5-fluorouracil (5-FU) KBv200, HepG2/R Bel-7402/5-FU, respectively. Morphological change determined Gimsa Hoechst 33258 staining. acumulation DOX confirmed spectrofluorimetric assay. Cell cycle analysis performed using flow cytometry. mRNA protein expression levels were assessed semiquantitative RT-PCR dot blot, results showed that at concentrations 0.0025%, 0.005%, 0.01% had little cytotoxicity. When combined with cancer drugs, it significantly promoted sensitivity cells. Fluorescence staining percentage apoptotic cell increased when Tween-20. This notion further supported observation treatment potentiated VIN-induced G2/M arrest cycle. Furthermore, intracellular accumulation DOX. blot revealed could downregulate P-glycoprotein. Low can efficiently multidrug phenotype enhancing anticancer drugs. may be via inhibiting multidrug-resistant gene expression.

参考文章(35)
Nissen Nn, Sehested M, Demant Ej, Jensen Pb, Friche E, The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. Cancer communications. ,vol. 2, pp. 297- 303 ,(1990)
Roger G. Deeley, Susan P. C. Cole, Douglas W. Loe, Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). Journal of Pharmacology and Experimental Therapeutics. ,vol. 293, pp. 530- 538 ,(2000)
Roger G. Deeley, Susan P.C. Cole, Substrate recognition and transport by multidrug resistance protein 1 (ABCC1) FEBS Letters. ,vol. 580, pp. 1103- 1111 ,(2006) , 10.1016/J.FEBSLET.2005.12.036
Bhagwant D Rege, Joseph P.Y Kao, James E Polli, Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers European Journal of Pharmaceutical Sciences. ,vol. 16, pp. 237- 246 ,(2002) , 10.1016/S0928-0987(02)00055-6
P.K. Dudeja, K.M. Anderson, J.S. Harris, L. Buckingham, J.S. Coon, Reversal of Multidrug-Resistance Phenotype by Surfactants: Relationship to Membrane Lipid Fluidity Archives of Biochemistry and Biophysics. ,vol. 319, pp. 309- 315 ,(1995) , 10.1006/ABBI.1995.1298
Suresh V Ambudkar, Chava Kimchi-Sarfaty, Zuben E Sauna, Michael M Gottesman, P-glycoprotein: from genomics to mechanism Oncogene. ,vol. 22, pp. 7468- 7485 ,(2003) , 10.1038/SJ.ONC.1206948
Kohei Tahara, Yoshitoyo Kato, Hiromitsu Yamamoto, Jörg Kreuter, Yoshiaki Kawashima, Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells Journal of Microencapsulation. ,vol. 28, pp. 29- 36 ,(2011) , 10.3109/02652048.2010.522258
Benjamin Tan, David Piwnica-Worms, Lee Ratner, Multidrug resistance transporters and modulation Current Opinion in Oncology. ,vol. 12, pp. 450- 458 ,(2000) , 10.1097/00001622-200009000-00011